NMN evidence is growing
Preclinical and clinical safety data includes [5] : No evidence of mutagenic activity, chromosomal aberrations, or micronucleus formation in genotoxicity studies 6-month chronic oral administration studies in rats showed no toxicological concerns 9-month studies in cynomolgus monkeys revealed general safety Six human clinical trials spanning 0.25 mg to 30 mg doses for up to 6 months No serious adverse events or withdrawals related to AOD9604 intake No anti-AOD9604 antibodies detected, indicating low immunogenic potential No changes in vital signs, physical examinations, electrocardiograms, or safety-related laboratory parameters Research Applications A Quick Review AOD9604 is a peptide compound that has shown potential in research related to lipid metabolism, energy balance, and tissue regeneration
In regards to water content, cream-vehicle treatment resulted in no changes in the mice subject to direct flame for 5 or 7 seconds
These peptides create pulsatile growth hormone release mimicking natural patterns without elevating cortisol or prolactin
Explore our prescription-strength injectable therapies designed to support cellular energy, metabolic function, and cognitive performance
After my first injection, I felt significant improvement the following day without feeling worse